Galmed Pharmaceuticals
GLMD
GLMD
30 hedge funds and large institutions have $19.4M invested in Galmed Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
0% less capital invested
Capital invested by funds: $19.5M → $19.4M (-$57.7K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
30
Holding in Top 10
–
Calls
$51K
Puts
–
Top Buyers
| 1 | +$116K | |
| 2 | +$91K | |
| 3 | +$79.6K | |
| 4 |
Two Sigma Advisers
New York
|
+$60K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$59K |
Top Sellers
| 1 | -$2.45M | |
| 2 | -$189K | |
| 3 | -$24K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$20.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$6K |